Abstract:
Two million people die per year due to pulmonary tuberculosis
all over the world.The
15 million new cases are diagnosed every year in India,of which 90% have pulmonary tuberculosis. Chronic
bronchitis is the second most common lung disorder after
pulmonary tuberculosis equally prevalent in rural and urban
areas. Similarly nearly 6% population suffers from Bronchial
asthma in India. Respiratory system is one
such in human body which gets affected from a variety of
infections and condition may become worse when body lacks
sufficient immunity. Though drugs like corticosteroids,
bronchodilators, anti tubercular therapy offer relief but may
have many side effects. In Ayurveda answer to these problems is
Rasayana therapy. Role of Rasayana therapy with recent
advancement can be adjusted in terms of immuno modulatory,
cytoprotective, genoprotective, adaptogenic, stress reliever
actions etc. In this study a textual formulation. ‘Pippali
Rasayana’ was given for a period of 45 days after Koshtha
shodhana to 15 patients diagnosed with common respiratory
diseases. Control group of 12 patients was observed as such
while taking their respective medications. A remarkable
improvement was noted in clinical features as well as general
conditions of these patients indicating the beneficial role of
‘Pippali Rasayana’ as adjuvant.
*
Lecturer in Kayachikitsa, Himalayiya Ayurvedic Medical College,
Shyampur, Dehradun **Professor
& Principal, P.G. Dept. of Kayachikitsa, R.G. Govt. P. G.
Ayurveda College, Paprola ***Professor,
P. G. Dept. of Kayachikitsa
